5 Stocks to Watch: Week of 11/16/2026
We've got a really good watchlist for you this week:
- Crescent Energy (CRGY): Experts project 80% upside following a high-profile deal
- Omada Health (OMDA): Experts believe this stock could double or more
- Cardinal Health (CAH): Supplies 75% of U.S. hospitals, #1 in industry
- Peloton Interactive (PTON): A blast from the past with a strong turnaround
- Vertiv Holdings (VRT): A great dip buy riding the AI data center buildout
Let's dig right in.
A note from our sponsors...
You Are the Exit Liquidity
When you buy a token on a major exchange, you're buying it from someone who got there first.
Take Solana.
It launched in March 2020, and Coinbase didn't list it until June 2021.
That's 15 months of trading... before it ever showed up in your app.
And when it finally did, the people already holding it got the one thing they needed... buyers.
They got their exit.
So where were they buying it all that time?
The Native Markets. The venues where assets trade BEFORE the big exchanges get around to listing them.
When you buy on major exchanges, you're the exit liquidity.
When you buy in the Native Markets, you're the early investor.
Watch How to Access the Native Markets Step-By-Step →
1- Cardinal Health (NYSE: CAH)
This company quietly distributes pharmaceuticals and medical products to 75% of hospitals in the U.S. With recent quarterly results demonstrating robust execution and an expanding market presence in medical distribution, the company sits atop its industry.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $278.14 — get current quote
Max 1-year forecast: $320.00
Why we're watching:
- CAH has strong, bullish coverage among the analysts we track, with 7 Strong Buy, 4 Buy, and 1 Hold recommendations. See all recommendations here
- For example, two top-rated analysts including Evercore ISI Group researcher Elizabeth Anderson (a top 13% rated analyst) and Morgan Stanley researcher Erin Wright (a top 5% rated analyst) recently maintained Strong Buy recommendations with upside targets suggesting the stock could see ample upside.
- It’s our Stock of the Week: Our Editor-in-Chief, Steve Reitmeister, has strong conviction regarding CAH, recently naming it his Stock of the week and praising it as “the poster child for ‘slow and steady wins the race’ investing” … making it the perfect selection for recent market volatility. See his full coverage here.
- Q2 earnings demonstrated execution strength: EPS of $12.80 beat estimates by 4.24% with 64.68% year-over-year growth, while revenue of $268.7B exceeded expectations by 4.25% with 10.37% YoY growth.
- Industry ranking context: CAH is currently the #1 highest-rated stock in the Medical Distribution industry, which has an Industry Rating of A.
- Zen Ratings highlights: CAH earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
- Component Grades: CAH delivers solid performance with strong Bs for Growth, Momentum, Safety, and Sentiment, a mix that reflects the company's stable operational trajectory and expanding market share in a critical healthcare sector. See all 7 Component Grades here
A note from our sponsors...
1 trade idea. 1 email. Every day.
Trusted by over 130,000 people, this free daily newsletter provides self-directed investors with tomorrow's trade idea, today sourced from top wall street analysts.
2- Crescent Energy (NYSE: CRGY)
This diversified oil and gas company is capitalizing on favorable energy market conditions and operational efficiency gains to drive shareholder value.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $12.04 — get current quote
Max 1-year forecast: $24.00
Why we're watching:
- CRGY has solid, bullish coverage among the analysts we track, with 6 Strong Buy, 2 Buy, and 1 Hold recommendations. See all recommendations here
- For example, Raymond James researcher John Freeman (a top 1% rated analyst) maintained his Strong Buy recommendation with a price target nearly 80% above current levels.
- Industry ranking context: CRGY is currently the #7 highest-rated stock in the Oil and Gas industry, which has an Industry Rating of B.
- Zen Ratings highlights: CRGY earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: CRGY excels for Growth with an A grade, reflecting the company's strong expansion trajectory in the energy sector, while maintaining solid Bs for Sentiment and Value, a combination that positions it well for continued appreciation. See all 7 Component Grades here
3- Omada Health (NASDAQ: OMDA)
This virtual healthcare-focused company is capitalizing on the growing digital health market and expanding its member base through strong partnerships with health plans and employers.
Zen Rating: B (Buy) — see full analysis
Recent Price: $15.24 — get current quote
Max 1-year forecast: $35.00
Why we're watching:
- OMDA has solid, bullish coverage among the analysts we track, with 6 Strong Buy, 2 Buy, and 2 Hold recommendations. See all recommendations here
- For example, Barclays researcher Saket Kalia (a top 2% rated analyst) maintained his Strong Buy recommendation with a price target suggesting the stock has over 45% upside potential from current levels.
- Better still, BTIG researcher David Larsen (a top 16% rated analyst) reiterated his Strong Buy with a price target over 130% above current levels.
- Industry ranking context: OMDA is currently the #7 highest-rated stock in the Health Information Service industry, which has an Industry Rating of A.
- Zen Ratings highlights: OMDA earns an overall A rating, which equals a Strong Buy recommendation. Stocks with this grade represent the elite performers based on a comprehensive 115-factor fundamental analysis framework.
- Component Grades: OMDA earns solid Bs for Sentiment, Financials, and Growth, reflecting analyst confidence and improving profitability, a mix that supports its digital health expansion strategy. See all 7 Component Grades here
4- Peloton Interactive (NASDAQ: PTON)
The pandemic-era stock superstar is back, and capturing renewed investor attention as it demonstrates profitability improvements and operational efficiency gains.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $5.61 — get current quote
Max 1-year forecast: $10.00
Why we're watching:
- PTON has limited, but overall bullish, coverage among the analysts we track, with 3 Strong Buy and 1 Strong Sell recommendations. See all recommendations here
- For example, Canaccord Genuity researcher Susan Anderson (a top 14% rated analyst) maintained her Strong Buy with a price target suggesting the stock could see over 40% share price appreciation in the coming year.
- Industry ranking context: PTON is currently the #2 highest-rated stock in the Leisure industry, which has an Industry Rating of B.
- Zen Ratings highlights: PTON earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: PTON stands out with an A for Financials alongside solid Bs for Growth, and Value, indicating the company has achieved strong fundamental improvement while offering compelling valuation potential. See all 7 Component Grades here
5- Vertiv Holdings (NYSE: VRT)
With AI driving unprecedented demand for data center capacity, this company is capturing transformational growth as hyperscalers and enterprises race to build out next-generation computing infrastructure.
Zen Rating: B (Buy) — see full analysis
Recent Price: $215.15 — get current quote
Max 1-year forecast: $500.00
Why we're watching:
- VRT has solid, bullish coverage among the analysts we track, with 7 Strong Buy, 8 Buy, and 1 Strong Sell recommendations. See all recommendations here
- For example, Evercore ISI Group researcher Amit Daryanani (a top 2% rated analyst) maintained his Buy with a price target nearly 60% above current levels.
- Better still, Citigroup researcher Andy Kaplowitz (a top 1% rated analyst) recently maintained his Strong Buy recommendation and a price target roughly 80% above current levels.
- Industry ranking context: VRT is currently the #4 highest-rated stock in the Electrical Equipment & Part industry, which has an Industry Rating of D.
- Zen Ratings highlights: VRT earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: VRT excels with straight As for Financials, Growth, and Sentiment, reflecting robust earnings power, expanding market opportunities, and strong analyst conviction — a combination positioning the stock for continued outperformance. See all 7 Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.